ELM-2 Exploratory ctDNA Analysis
ELM-2 Exploratory Analysis: Association Between ctDNA-Assessed Measurable Residual Disease Status and PFS With Odronextamab in R/R FL and DLBCL

Released: December 13, 2023

Activity

Progress
1
Course Completed